Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

ClinicalTrials.gov ID: NCT05936151

Public ClinicalTrials.gov record NCT05936151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will last around 31 weeks.

Study identification

NCT ID
NCT05936151
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
146 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 20, 2023 (Actual)
Primary completion
Oct 1, 2025 (Actual)
Completion
Oct 21, 2025 (Actual)
Last update posted
Nov 25, 2025

2023 – 2025

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
18
Facility City State ZIP Site status
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa Chandler Arizona 85225 —
Care Access - 801 South Power Road, Mesa Mesa Arizona 85206 —
Headlands Research - Scottsdale Scottsdale Arizona 85260 —
Medical Advancement Centers of Arizona Tempe Arizona 85283 —
Hope Clinical Research, Inc. Canoga Park California 91303 —
Catalina Research Institute, LLC Montclair California 91763 —
Peninsula Research Associates Rolling Hills Estates California 90274 —
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 —
Teradan Clinical Trials, LLC Brandon Florida 33511 —
Suncoast Clinical Research, Inc. New Port Richey Florida 34652 —
Great Lakes Clinical Trials - Ravenswood Chicago Illinois 60640 —
Indiana University Health University Hospital Indianapolis Indiana 46202 —
Prime Health and Wellness/SKYCRNG Fayette Mississippi 39069 —
Palm Research Center Tenaya Las Vegas Nevada 89128 —
NYU Langone Hospital - Long Island Mineola New York 11501 —
Cleveland Clinic Cleveland Ohio 44195 —
Victorium Clinical Research - Houston Houston Texas 77024 —
Endocrine Ips, Pllc Houston Texas 77079 —
Tranquility Research Webster Texas 77598 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05936151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2025 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05936151 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →